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Abstract
Background: Large populations are exposed to smoke from bushfires and planned burns. Studies investigating the
association between bushfire smoke and health have typically used hospital or ambulance data and been done
retrospectively on large populations. The present study is designed to prospectively assess the association between
individual level health outcomes and exposure to smoke from planned burns.
Methods/design: A prospective cohort study will be conducted during a planned burn season in three locations in
Victoria (Australia) involving 50 adult participants who undergo three rounds of cardiorespiratory medical tests,
including measurements for lung inflammation, endothelial function, heart rate variability and markers of inflammation.
In addition daily symptoms and twice daily lung function are recorded. Outdoor particulate air pollution is
continuously measured during the study period in these locations. The data will be analysed using mixed effect
models adjusting for confounders.
Discussion: Planned burns depend on weather conditions and dryness of ‘fuels’ (i.e. forest). It is potentially possible
that no favourable conditions occur during the study period. To reduce the risk of this occurring, three separate
locations have been identified as having a high likelihood of planned burn smoke exposure during the study period,
with the full study being rolled out in two of these three locations. A limitation of this study is exposure
misclassification as outdoor measurements will be conducted as a measure for personal exposures. However this
misclassification will be reduced as participants are only eligible if they live in close proximity to the monitors.
Keywords: Planned burn smoke, Forest fire smoke, Lung inflammation, Endothelial function, Markers of inflammation,
Particulate matter (PM)
Background
Fire has been integral to Australian landscapes for mil-
lennia and vegetation across the continent is highly fire
adapted and often fire promoting, as some species re-
quire severe fires for reproduction. Smoke is therefore
a characteristic feature of Australian biophysical envir-
onment and intermittent exposure to fire smoke is in-
evitable for the majority of Australians [1, 2]. Major
urban areas, including population centres far from
areas of native vegetation, are routinely affected by se-
vere air pollution episodes from landscape fires as
smoke can be transported in the atmosphere for long
distances [3, 4].
Current evidence suggests that public health harm
from bushfires, is likely to be minimised by proactive
management through planned burning, rather than
relying on reactive management of severe bushfires as
they arise [5, 6]. However planned burning to reduce
fuel loads, is an important source of exposure to poor
air quality [7]. There is strong evidence that extreme
pollution from severe, infrequent forest fires contrib-
utes to mortality, hospital admissions, and emergency
attendances especially for respiratory conditions [8, 9]
and some cardiovascular illnesses [10, 11]. However, it
is not known if similar risks can be expected at the
lower concentrations of smoke derived particulate
matter (PM) generally associated with planned burns.
The populations affected are usually smaller rural
* Correspondence: dok1@iinet.net.au
1Department of Epidemiology and Preventive Medicine, School of Public
Health and Preventive Medicine, Monash University, Level 6 The Alfred
Centre, 99 Commercial Road, Melbourne 3004, Australia
Full list of author information is available at the end of the article
© 2016 O’Keeffe et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
O’Keeffe et al. BMC Public Health  (2016) 16:186 
DOI 10.1186/s12889-016-2862-y
communities that do not lend themselves to large scale
population based epidemiological studies because of ab-
sent air quality monitoring data, or because relative
small populations mean that outcomes such as hospital
admissions and deaths are infrequent and not useful for
the study of broad episodes of smoke pollution. Evalu-
ation of individual clinical impacts or changes in bio-
markers in association with exposure to smoke from
planned burns is a practical approach to evaluating po-
tential health impacts of landscape fire smoke in small
populations.
Individual clinical and toxicological impacts of urban
background PM has been more widely studied than
landscape fire derived PM. It is now generally accepted
that changes in respiratory function in response to PM
occurs through the promotion of inflammation and
other pathways including increasing oxidative stress
[12]. Impacts on cardiovascular health are thought to be
mediated via the promotion of systemic inflammation
pro-oxidation, coagulation and changes in heart rhythms
from interaction with particles [13].
Most bushfire smoke research to date most has been
population based epidemiological studies examining rou-
tinely collected hospital or mortality data. [14–17]. How-
ever there is an emerging literature examining individual
clinical and subclinical endpoints [18]. Health out-
comes relevant at an individual level include cardiore-
spiratory symptoms, medication and health service
usage, lung function, airway inflammation, blood pres-
sure, heart rate variability, endothelial function and
inflammatory markers in blood. These have been pre-
viously investigated in studies of urban air pollution
[19–21], but not yet widely applied to bushfires or at
all to planned burns.
Studies specific to landscape vegetation fires are un-
common but findings have generally been consistent
with the above findings for PM from other, (non-fire)
sources. During a series of clinical studies, brief expos-
ure to biomass smoke has been associated with short-
term changes in inflammatory cells and other markers
[22, 23]. Through in-vivo animal studies, the wildfire-
derived PM exposure compared to controls have demon-
strated lower counts of lung macrophages, but higher
levels of inflammatory cytokines [24, 25]. Finally with in-
vitro studies, rat alveolar macrophages exposed to PM2.5
from prescribed fires showed increased inflammation
compared to controls. Human bronchial epithelial cells
exposed to wildfire-derived PM2.5 compared to cells ex-
posed to ambient PM also showed increased inflamma-
tory markers [12, 26].
This study is designed to evaluate the relationship be-
tween exposure to smoke from planned burns and ef-




The aim is to assess health impacts of smoke, as measured
by PM2.5 from planned burns in rural communities.
This is a prospective cohort study that is conducted
during a planned burning season, the planned burn
season occurs in late spring/early summer and late
summer/early autumn in the southern hemisphere. Ap-
proximately 50 participants undergo three rounds of
health assessments over a three to four month period:
before, during and after the smoke exposure from
planned burning. To ensure we have relatively “clean
air” we will need two weeks of no smoke exposure
prior to the “before” phase of data collection, this also
means that no bushfires or smoke events should take
place in or near the collection sites. In addition, the
participants keep a diary of respiratory symptoms and
lung function for about six weeks. PM2.5 exposure data
is measured during the planned burning season at a
central site in each of the study locations. Every partici-
pant will receive standardised individual training, and
supervised standard measurements will be collected at
the “before” assessment.
Hypothesis
Our primary hypothesis is that elevation in the levels of
PM2.5 from planned burning will lead to a decrease in
cardiorespiratory health, and increases in inflammatory
mediators.
Setting
The study sites are three towns in the state of Victoria,
Australia. We identified three areas where the before
measurements are to be conducted. The three study
sites have already been identified in discussion with the
Victorian Department of Environment, Land, Water and
Planning (DELWP). The criteria to determine these
three sites are as follows:
 High likelihood of significant smoke exposure from
planned burns
 Large enough population to enable recruitment of
sufficient participants
 Within three hours drive of Melbourne (due to the
short notice we would be unable to fly to the
relevant locations)
The three sites chosen to conduct the study in are:
1) Warburton, a town of approximately 2,200 people
on the Yarra River within the Little Yarra Valley.
Warburton is 72 kilometres from Melbourne.
2) Traralgon, a large regional centre of approximately
24,000 people in the Latrobe Valley region of
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Victoria. It is approximately 160 kilometres from
Melbourne.
3) Maffra and Heyfield are two distinct townships in
the Shire of Wellington, Victoria. Heyfield is 206
kilometres from Melbourne and has a population of
approximately 2,100 people. Maffra is 220
kilometres from Melbourne with a population of
approximately 4,200 people. Due to their relative
proximity and similar smoke exposures due to
geography, the results from Maffra and Heyfield
will be collated as one site.
Most of the sites are visited over several days to collect
the health data.
Planned burning operations are unpredictable in tim-
ing as they depend on climatic conditions and dryness of
the ‘fuel’ (i.e. forest). It is even possible that due to un-
favourable conditions no burning takes place in a certain
region in a particular season. To minimise the risk of no
exposure to smoke in our study, three locations are indi-
cated as suitable, with the full study rolled out in these
three locations, depending on smoke exposure.
Study population
The aim is to study 50 adults, who live in one of the
three identified study sites, and are over 18 years of age.
As older age is a risk factor for adverse health outcomes
from air pollution, we aim to have half the participants
aged over 65 years. There are no exclusion criteria based
on current health or medical conditions. The only exclu-
sion criterion for participation is, the participant must
be aged 18 years and above. Informed consent will be
obtained in writing from each participant.
We will collect information on pre-existing diseases
and other existing conditions, e.g. we have detailed
questions about asthma, COPD, other respiratory dis-
eases. We ask specifically about inflammatory diseases,
whether they have high blood pressure and heart condi-
tions (heart failure, arrhythmia etc.) in the question-
naire and these will be included as covariates in
analysis.
Whilst the study will require a minimum of 50 partici-
pants from across the three sites for statistical power, it
is envisaged that the study will attempt to recruit the
same number of participants from each site for the
study. It is not necessary for the 50 participants to be
evenly distributed across all three collection sites. A co-
variate will be added in the analysis for location.
There are consistent associations in older persons
between bushfire particulate and respiratory hospital
admissions [8–10], beyond the underlying effect of ex-
posure to particulates from urban sources. The stron-
gest association with bushfire particulate was for
COPD and other respiratory conditions [27].
Recruitment
Prior to recruitment the study is advertised in the main-
stream media, local media, and on social media, followed
by recruitment by a professional recruitment/research
agency that does random digit calling within the study
area. In addition a Facebook page is set up and a free
call 1800 number assigned to the study. As an added in-
centive participants are offered the chance to go into a
draw that rewards them with a voucher after each round
of measurements.
By using a market research company to target the
three site locations to identify potential participants we
anticipate a greater number of people will agree to
participate in the study. Through cold-calling, people
who live in the catchment areas of the study are
called on their home phone numbers and asked to
participate in the study. A brief outline of the study
is explained to them.
In contacting participants we will need to conduct
follow-up telephone calls to each person as the dates for
the planned burns will be weather dependent. Notice of
definite planned burns will be relayed to the study team
a few days before the event. The study team will then
contact all the participants informing them that the
study team will be in the town to carry out data collec-
tion on the said days and book a set time for the partici-
pant to attend the study.
Exposure measurements
At a central location in each of the study areas an E-
sampler Aerosol Monitor (MetOne Instruments Inc.
Grants Pass OR), is set up. The E-sampler measures
concentrations of PM2.5 (particles with an aerodynamic
diameter of less than 2.5 μm). It provide continuous
real-time measurements by light –scattering which as-
sists in evaluating peak concentrations, and it also col-
lects gravimetric measurements on filters, which are
used to determine a calibration factor for the E-sampler.
The weekly gravimetric samples are collected on pre-
weighed 47 mm Fluoropore filters, which are also used
for analysis of levoglucosan, a biomass burning marker.
Participants also keep a daily diary which indicates
whether they spent the majority of the day in or outside
the study area. The samplers will be deployed for the en-
tire period of the study.
The samplers will be connected to a mains power out-
let, and located in an area that is secure and tamper
proof. The samplers will be in a central location relative
to most participants. In the situation of fire smoke an
entire rural community is usually affected by a smoke
plume and within each individual community exposure
from this source has greater homogeneity of distribution
than distributed point sources such as wood heaters.
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Additionally we will sample indoor and outdoor Par-
ticulate Matter (PM) concentrations at (six) selected in-
dividual houses located throughout each study site to
evaluate the representativeness of the central monitor
and the relationship between indoor and outdoor con-
centrations of PM. The indoor/outdoor measurements
will be spread across the data collection area. One of the
requirements is that it will be centrally located in the
study area away from any point sources so it would be
representative of concentrations in the study area.
The QA/QC program will be similar to that used
in previous studies [28, 29]. Gravimetric mass and
analytical measurements will be conducted at the
NATA- accredited laboratories at CSIRO Oceans and
Atmosphere laboratory. Levoglucosan will be determined
by high-performance anion-exchange chromatography
with pulsed amperometric detection (HPAEC-PAD).
Levoglucosan will be separated from other anhydrous
sugars such as galactosan and mannosan with a 4 mm ×
250 mm CarboPac PA10 analytical column protected by a
4 mm × 50 mm CarboPac PA10 guard column. The devel-
opment of the HPAEC-PAD technique is based on a pre-
vious study to measure levoglucosan in PM2.5 from
biomass combustion [30]. NATA-accredited gravimetric
mass measurements on the pre-exposed and exposed fil-
ters will be made using a Mettler UMT2 ultra-
microbalance with a specialty filter pan in a temperature
and humidity controlled environment.
Health outcome measurements
Participants visit a central location in each study area
where health measurements are performed on three oc-
casions, before, during and after exposure to smoke
from planned burns. The data will be collected at three
sites that are accessible to the public and located in a
venue within or immediate to the town centre.
In addition daily health outcome data is collected and
starts on the first (‘before’) visit. The “before” measure-
ments will occur approximately two weeks before the
planned burns occur. The study will need to take into
consideration the long time frame if we decide to collect
data months in advance so we have decided to collect a
few weeks prior to the scheduled planned burns in the
hope that they will occur as planned. The same staff will
collect data from all three sites in the study.
The following data will be collected:
(I) Initial Questionnaire: On the first visit includes
questions on age, general health, occupation and
period of time living in the study area.
(II) Daily Diary and self-measured lung function for
6–12 weeks
 The participants record in their daily diary
information on daily cardiorespiratory symptoms,
medication use and health service usage (i.e. GP
or hospital attendances) and whether they take
measures to reduce their exposure to smoke (i.e.
stayed inside as much as possible, reduced
outdoor activity, closed windows and doors or
wore a mask). The daily diary will ask
participants to record inside and outside
movement over the course of the study. This will
be matched to smoke events over the course of
the study.
Lung function testing: Every morning and evening
the participants measure their lung function using a
portable electronic PiKo-6 (nSpire Health, Longmont
CO) meter. PiKo-6 displays and stores the test results
including the ratio of FEV1/FEV6. Self-measured lung
function is less accurate than supervised measurement
in a laboratory. However any measurement error
is likely to be non-differential meaning that effect
estimates would be biased towards the null.
(III) Clinical testing on three occasions (before, during
and after smoke exposure)
 Lung inflammation test using an Aerocrine
(Aerocrine AB, Solna, Sweden) NiOx Unit which
measures exhaled nitric oxide. Exhaled nitric
oxide (eNO) is a simple, non-invasive and
reproducible method to measure airway
inflammation.
 Blood pressure test using an Omron (Omron
Global, Kyoto, Japan) Premium Automatic Blood
Pressure Monitor HEM-7211
 Heart rate variability and markers of cardiac
ischaemia using 24 hour electrocardiography
(Holter monitor). This is done on selected
participants as we only have 10 monitors
available, and we test more than 10 participants
per day. Participation in this part of the study will
be based on people being willing to wear the
Holter monitor for a 24 hour period.
 Endothelial function measured by (i) Finger
plethysmography and (ii) flow mediated
dilatation of the brachial artery. The finger
plethysmography endothelial function
measurement is measured via peripheral artery
tonometry using the portable EndoPAT 2000
instrument (Itamar Medical Ltd, Cesari, Israel),
which calculates the Reactive hyperaemia
index. The flow-mediated dilatation (FMD)
test is an ultrasound method to assess the
ability of the arteries to respond with
endothelial NO release during hyperaemia
(flow mediated) after a 5 minute occlusion of
the brachial artery with a blood pressure cuff.
The endothelia measurements will take
approximate 30 minutes.
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 Blood tests, for blood markers of inflammation
and coagulation. Venous blood (around 15 ml) is
drawn by experienced field staff. Blood is then
centrifuged and the resulting plasma and serum
tested for: High sensitivity C-reactive protein,
Fibrinogen, and the Full Blood Examination
will be performed on whole blood (including
haemoglobin, platelet count, White Cell
Count). Study researchers/field staff including
qualified nurses with training and prior
experience in collecting blood samples are
employed for the purposes of the study.
Additionally appropriate training and
supervision is provided to the researchers/field
staff who are assisting in conducting other
health measurements for the study.
Blood collection will be conducted by either a phlebot-
omist or registered nurse and stored within the guide-
lines as recommended by the Australian National Blood
Authority in regard to receipt, storage, collection and
transportation of blood. The blood will be stored in
temperature controlled refrigeration unit specifically
used for blood collection and storage. Transport of the
blood will be conducted by a specialised courier service
that will transport the specimens to a pathology labora-
tory for analysis. Analysis will take place at the NATA
accredited Alfred Hospital Pathology Service laboratories
by trained and qualified haematologists or technicians.
The blood samples collected will be stored for future
analysis by the researchers should funding be made
available for subsequent studies.
The study will provide participants with information
on any abnormal readings for them to follow-up with
their local health provider.
The researchers are first-aid trained and can deal with
issues such as breathlessness, feeling light headed, faint-
ing or bruising. There is a review after each health meas-
urement collection to ensure correct data collection
procedures. Researchers are made aware of confidential-
ity agreements. In the case of any adverse/unforeseen
events in relation to the collection, use or disclosure of
information, the Chief Investigator will inform the
Monash University Human Research Ethics Committee
(MUHREC) as soon as possible.
Data management
Data will be retained for at least five years. Storage of
data adheres to the University regulations and kept on
University premises in a locked cupboard/filing cabinet
and password protected database on the University com-
puter network. Only the researchers named in this pro-
ject will have access to this data. The study results will
report aggregated data. No individual’s name will be
associated with any published or unpublished report
from this study.
Ethics approval
This research study has been approved by the Monash
University Human Research Ethics Committee CF12/
3097-2012001570 and the Human Research Ethics
Committee of the University of Tasmania, reference
number H0013022.
Statistical analysis
Mixed effect models, adjusting for confounders, will be
used for analysis. Exposure to PM2.5 is the independent
variable and the health outcomes are the dependent vari-
ables. For each health outcome a regression coefficient
and 95 % confidence interval is calculated for an inter-
quartile range increase in PM2.5 (This increase is a real-
istic increase and will be based on the difference
between no smoke exposure and smoke exposure in the
study locations). Data is analysed using Stata and R stat-
istical software package.
Sample size
The sample size for this study (50 subjects) measured on
three occasions, is sufficient to find significant effects.
Studies using the same end-points have found signifi-
cant effects using lesser number of participants and
observations.
For example two studies related to traffic exposures vs
no traffic exposure found significant effects on exhaled
nitric oxide [19, 31]. The first study measured 36 partici-
pants on three occasions and the second measured 60
participants on two occasions and both found significant
associations with eNO. Our estimated sample population
of 50 participants measured three times, together with
the high likelihood that the PM2.5 concentrations in the
two studies are lower than the concentrations that will
occur in the present study, will be sufficient to find an
effect if there is one.
Another example is an intervention study from
Canada using HEPA filters indoor, which investigated
the association between wood smoke exposure and
RHI (marker of endothelial function) and C-reactive
protein (CRP - marker of inflammation in the blood)
in 45 participants on two occasions. They found sig-
nificant associations for both RHI and CRP whereas
concentrations are expected to be an order of magni-
tude higher in our study [32].
Previous studies have suggested that increased exposure
to PM2.5 is associated with increased levels of CRP [33].
Based on the largest study conducted in a general popula-
tion we estimated the mean population CRP level will be
approximately 2.7 mg/L with a standard deviation of
4.9 mg/L [34]. Previous effect sizes have shown varied
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results [35]. A previous study indicated that a 99.1 % in-
crease in CRP was observed per 34.5 ug/m3 increase in
PM2.5 [10]. Although this study was conducted in younger
patients, which tend to have a lower baseline CRP level
(0.8 mg/L in this study), the exposure difference in our
study is anticipated to be larger; approximately 60 μg/m3
difference in PM2.5 levels between the unexposed and ex-
posed periods. A US study in older persons (mean CRP =
2.4, SD = 3.2), suggested a change of 0.75 mg/L per 7.0 ug/
m3 of PM2.5 [13]. Thus for an increase of 60 μg/m
3 in
PM2.5 we’d expect to see an increase of 6.43 mg/L in CRP
[(60/7)*0.75]. Using a population mean of 2.7, a conserva-
tive expected increase of 2.7 with a population standard
deviation of 4.9, the estimated sample size for two-
sample comparison of mean CRP levels can be calcu-
lated as 52. As CRP is our primary outcome in our
study we have powered this study to be able to see a
signal on this biomarker. However we will also be in-
vestigating the associations between PM2.5 and the
other biomarkers, like fibrinogen.
Discussion
A strength of this study is that it collects individual level
health data and not population level data. This allows in-
vestigation of subclinical health outcomes which has not
been done to date in relation to planned burn smoke ex-
posure in the community[36]. Another strength is the
large difference in particulate matter concentration dur-
ing smoke exposure compared to no smoke exposure.
Most studies have investigated urban air pollution or
traffic air pollution and these differences are about an
order of magnitude lower than what is experienced dur-
ing smoke from planned burns in the local communities.
One of the key challenges involved in a study such as
this is the process whereby the study team is informed
of the dates of the planned burns by the relevant author-
ities and the short time frame that will be required to
contact potential participants. The aim is to perform the
‘before’ assessment within 2 weeks of the planned burns
occurring. The assessment after the burns will be done
once there has been no smoke in the area for 2 weeks.
That should be enough time for the health measures to
return to baseline and give an indication of possible long
term effects of the smoke if measures have not returned
to baseline levels at this stage. As the study is susceptible
to changes in weather, it is proposed that data collection
will occur either during the spring or autumn to reduce
the possibility of data collection being compromised by
bushfires during the warmer summer months, or heavy
rains during the winter months [37]. The authorities
conducting the planned burns require that there is no
rainfall several days prior to a planned burn, and that no
rain falls during the planned burn. This is to maximize
the opportunity to burn off the undergrowth that feed
bushfires. This can lead to the study being delayed or
postponed if weather conditions are not favorable for
the planned burns. As such the study will need to keep
participants informed of potential follow-up dates with
the possibility of sudden cancellations. This may also
lead to potential participants not being available on the
date collection days are due to take place because of
other commitments.
A limitation of this study is exposure misclassification.
Air pollution measurements are conducted at a central
location at each study location. However as we do not
have personal exposures during the study this may lead
to misclassification as the outdoor concentration is not
necessarily the same as the personal exposure of an indi-
vidual participant. However it is common practice to use
outdoor exposure estimates as a proxy for personal ex-
posure in air pollution epidemiology. We collect daily
information on the amount of time the participant re-
sides in the study area and this is used to reduce expos-
ure misclassification.
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